This phenotypic similarity suggests that, in the absence of tau biomarker information, CSF A + T − and A + T + individuals may appear clinically similar, and their cognitive impairment could be interpreted as stemming from a shared underlying pathology—namely ADNC [69]. This evidence concerns the gene MAPT and Cognitive impairment.